Enovis logo

Enovis

ENOV | NYSE
Chart Builder DCF Calculator
$27.92
+$0.24 (+0.87%)
At close: Nov 16, 2026, 4:00 PM ET
$27.92
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET
+0.87%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31.8
Fundamentals Weak
Market Sentiment Bullish
Moat Narrow
Sector Rank #749/1021 (Top 73%)

Key Statistics

Market Data

Market Cap $1.61B
1D Range
27.55 28.37
52W Range
17.43 31.42

Valuation (TTM)

PE -3.01
PB 1.08
EV/EBITDA -17.54

Valuation (NTM)

Forward PE 7.48
Forward PEG -0.19
Price Target $38.00
Loading financial charts...

Profile

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of h...

Sector Healthcare
Employees 7,802
IPO Date May 8, 2008
Fiscal Year January - December

Latest News

Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London

4 days ago · globenewswire.com

Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
What Enovis (ENOV) Said on Its Q3 Earnings Call

10 days ago · marketbeat.com

What Enovis (ENOV) Said on Its Q3 Earnings Call
Enovis Corporation (ENOV) Q3 2026 Earnings Call Transcript

11 days ago · seekingalpha.com

Enovis Corporation (ENOV) Q3 2026 Earnings Call Transcript
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates

12 days ago · zacks.com

Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
ENOVIS Announces Third Quarter 2026 Results

12 days ago · globenewswire.com

ENOVIS Announces Third Quarter 2026 Results
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th

1 month ago · globenewswire.com

Enovis to Host Third Quarter 2026 Results Conference Call on November 5th

2 months ago · prnewswire.com

Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
What Makes Enovis (ENOV) a New Buy Stock

2 months ago · zacks.com

What Makes Enovis (ENOV) a New Buy Stock
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

2 months ago · zacks.com

Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition

3 months ago · zacks.com

Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition

Earnings

Latest Earnings
Nov 5, 2026
EPS
$0.88
Beat +14.73%
REV
$558.73M
Beat +0.29%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$38.00
Upside
+36.10%
Buy (7)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.